Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.

Freeman EW, Rickels K, Sondheimer SJ, Polansky M, Xiao S.

Am J Psychiatry. 2004 Feb;161(2):343-51.

PMID:
14754784
2.

Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.

Kornstein SG, Pearlstein TB, Fayyad R, Farfel GM, Gillespie JA.

J Clin Psychiatry. 2006 Oct;67(10):1624-32.

PMID:
17107257
3.

Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.

Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, Parry B, Pearlstein T, Severino S, Stout A, Stone A, Harrison W.

JAMA. 1997 Sep 24;278(12):983-8.

PMID:
9307345
4.

Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.

Freeman EW, Rickels K, Sondheimer SJ, Polansky M.

Arch Gen Psychiatry. 1999 Oct;56(10):932-9.

PMID:
10530636
5.

Predictors of response to sertraline treatment of severe premenstrual syndromes.

Freeman EW, Sondheimer SJ, Polansky M, Garcia-Espagna B.

J Clin Psychiatry. 2000 Aug;61(8):579-84.

PMID:
10982201
6.

Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.

Halbreich U, Smoller JW.

J Clin Psychiatry. 1997 Sep;58(9):399-402.

PMID:
9378691
7.

Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.

Yonkers KA, Pearlstein T, Fayyad R, Gillespie JA.

J Affect Disord. 2005 Apr;85(3):317-21.

PMID:
15780701
8.

Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.

Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA.

J Clin Psychiatry. 2000 Feb;61(2):101-9.

PMID:
10732657
9.

Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.

Halbreich U, Bergeron R, Yonkers KA, Freeman E, Stout AL, Cohen L.

Obstet Gynecol. 2002 Dec;100(6):1219-29.

PMID:
12468166
10.

Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.

Yonkers KA, Kornstein SG, Gueorguieva R, Merry B, Van Steenburgh K, Altemus M.

JAMA Psychiatry. 2015 Oct;72(10):1037-44. doi: 10.1001/jamapsychiatry.2015.1472.

PMID:
26351969
11.

Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.

Jermain DM, Preece CK, Sykes RL, Kuehl TJ, Sulak PJ.

Arch Fam Med. 1999 Jul-Aug;8(4):328-32.

PMID:
10418540
12.

Time to relapse after short- or long-term treatment of severe premenstrual syndrome with sertraline.

Freeman EW, Rickels K, Sammel MD, Lin H, Sondheimer SJ.

Arch Gen Psychiatry. 2009 May;66(5):537-44. doi: 10.1001/archgenpsychiatry.2008.547.

13.

[Psychiatric and psychological aspects of premenstrual syndrome].

Limosin F, Ades J.

Encephale. 2001 Nov-Dec;27(6):501-8. Review. French.

PMID:
11865558
14.
15.

Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial.

Freeman EW, Rickels K, Sondheimer SJ, Wittmaack FM.

J Clin Psychiatry. 1996 Jan;57(1):7-11.

PMID:
8543554
16.

Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant.

Freeman EW, Rickels K, Arredondo F, Kao LC, Pollack SE, Sondheimer SJ.

J Clin Psychopharmacol. 1999 Feb;19(1):3-8.

PMID:
9934936
17.

Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.

Cohen LS, Miner C, Brown EW, Freeman E, Halbreich U, Sundell K, McCray S.

Obstet Gynecol. 2002 Sep;100(3):435-44.

PMID:
12220761
18.

Venlafaxine in the treatment of premenstrual dysphoric disorder.

Freeman EW, Rickels K, Yonkers KA, Kunz NR, McPherson M, Upton GV.

Obstet Gynecol. 2001 Nov;98(5 Pt 1):737-44.

PMID:
11704162
19.

Efficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorder.

Cohen LS, Soares CN, Lyster A, Cassano P, Brandes M, Leblanc GA.

J Clin Psychopharmacol. 2004 Oct;24(5):540-3.

PMID:
15349012
20.

Variable dosing of sertraline for premenstrual exacerbation of depression: a pilot study.

Miller MN, Newell CL, Miller BE, Frizzell PG, Kayser RA, Ferslew KE.

J Womens Health (Larchmt). 2008 Jul-Aug;17(6):993-7. doi: 10.1089/jwh.2007.0491.

PMID:
18681820
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk